Shareholders of healthcare-at-home specialist Amedisys voted in favor of the roughly $3.3 billion pending acquisition by Optum, a subsidiary of UnitedHealth Group, in keeping with a Securities and Exchange Commission filing.
The shareholders authorized the adoption of the merger settlement, in addition to compensation to the corporate’s government officers in reference to the merger.
Nonetheless, the deal continues to be underneath evaluate by the Division of Justice.
Amedisys filed notifications of the merger with the Federal Commerce Fee and Antitrust Division of the Division of Justice in July, and in an SEC filing final month mentioned it obtained a request for extra data from the DOJ, extending the HSR Act ready interval till the events have fulfilled the DOJ’s calls for.
Although shareholders have authorized the deal, its finalization is topic to approval from sure state regulatory and authorities authorities.
THE LARGER TREND
In June, UnitedHealth Group announced its plans to purchase the Louisiana-based residence healthcare supplier in an all-cash deal, beating out Choice Care Well being.
In accordance with a Could SEC filing, Choice Care Well being entered into an Settlement and Plan of Merger with the house well being firm in an all-stock provide, however only one month later entered right into a termination settlement that included a termination charge of $106 million payable inside 24 hours of the execution of the settlement.
In February, United Healthcare finalized its acquisition of one other residence well being firm, LHC Group, in a $5.4 billion deal, additional increasing its attain within the residence healthcare market.
